All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

39

Reset

39 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • REGN7508CenvacibartPhase 312 trials

    Regeneron · Atrial Fibrillation (AF), Venous Thromboembolism (VTE), Venous Thromboembolism

  • LP-003SinglePhase 39 trials

    Longbio Pharma · Allergic Asthma, Chronic Spontaneous Urticaria (CSU), Peanut Allergies

  • hUC-MSCsmesenchymal stem cells, MSCPhase 38 trials

    Shenzhen Wingor Biotechnology Co., Ltd. · Knee Osteoarthritis, Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)

  • AbelacimabMAA868Phase 33 trials

    Anthos Therapeutics, Inc. · Atrial Fibrillation (AF), Stroke

  • MilvexianJNJ-70033093, BMS-986177Phase 33 trials

    Johnson & Johnson (Janssen) · Ischemic Stroke; Ischemic Attack, Transient, Atrial Fibrillation, Acute Coronary Syndrome

  • TAK-755rADAMTS13, recombinant ADAMTS13Phase 33 trials

    Takeda · Thrombotic Thrombocytopenic Purpura (TTP), Acute Ischemic Stroke

  • MLC1501Phase 32 trials

    Moleac Pte Ltd. · Stroke, Stroke, Ischemic, Strokes Thrombotic

  • SovateltideIRL-1620, PMZ-1620Phase 32 trials

    Pharmazz, Inc. · Traumatic Brain Injury, Acute Ischemic Stroke, Cerebral Stroke

  • JX10Phase 31 trial

    Corxel Pharmaceuticals · Acute Ischemic Stroke

  • Supergene, LLC · Ischemic Stroke, Acute

  • OtaplimastatSP-8203Phase 31 trial

    Shin Poong Pharmaceutical Co. Ltd. · Ischemic Stroke

  • Recombinant Human ProurokinaserhPro-UKPhase 31 trial

    Tasly Biopharmaceuticals Co., Ltd. · Acute Ischemic Stroke AIS

  • SHPL-49Phase 31 trial

    Shanghai Hutchison Pharmaceuticals Limited · Acute Ischemic Stroke

  • SIM0811Phase 31 trial

    Jiangsu Simcere Pharmaceutical Co., Ltd. · Acute Ischemic Stroke AIS

  • NeflamapimodVX-745Phase 24 trials

    EIP Pharma Inc · Nonfluent Variant Primary Progressive Aphasia (nfvPPA), Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke

  • RimonabantPhase 24 trials

    Sinfatin S.L · Chronic Stroke, Subacute Stroke, Post-COVID-19 Syndrome

  • SecretomeConditioned, Umbilical Cord Mesenchymal Stem Cells derived ConditionedPhase 24 trials

    PT. Prodia Stem Cell Indonesia · Acute Respiratory Distress Syndrome, Androgenetic Alopecia, Ischemic Stroke

  • Umbilical Cord Mesenchymal Stem CellsMesenchymal stromal cells, Allogeneic Mesenchymal Stem CellsPhase 24 trials

    PT. Prodia Stem Cell Indonesia · Diabetic Nephropathy Type 2, Ischemic Stroke, Cerebral Palsy

  • LT3001Phase 23 trials

    Lumosa Therapeutics Co., Ltd. · Acute Ischemic Stroke

  • ALT001Phase 22 trials

    Darwin Origin (Hubei) Biopharmaceutical Co., Ltd. · Ischemic Stroke in the Sequelae Stage, Amyotrophic Lateral Sclerosis (ALS)

  • LT3001 DrugPhase 22 trials

    Shanghai Pharmaceuticals Holding Co., Ltd · Acute Ischemic Stroke

  • TS23Phase 22 trials

    Translational Sciences, Inc. · Ischemic Stroke, Pulmonary Embolism

  • TTI-0102cysteamine-pantetheine disulfidePhase 22 trials

    Thiogenesis Therapeutics, Inc. · Nephropathic Cystinosis, Cystinosis, MELAS Syndrome

  • ASP2246Phase 21 trial

    Astellas · Chronic Ischemic Stroke

  • B2065Phase 21 trial

    Tasly Pharmaceutical Group Co., Ltd · Acute Ischemic Stroke

  • BB-031DTRI-031Phase 21 trial

    Basking Biosciences, Inc. · Acute Ischemic Stroke

  • HRS-4029Phase 21 trial

    Beijing Suncadia Pharmaceuticals Co., Ltd · Acute Ischemic Stroke

  • HRS-7450Phase 21 trial

    Fujian Shengdi Pharmaceutical Co., Ltd. · Acute Ischemic Stroke

  • IW-6463CY6463, zagociguatPhase 21 trial

    Tisento Therapeutics · Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)

  • MT200605Phase 21 trial

    Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Acute Ischemic Stroke

  • NCS-01Phase 21 trial

    NC Medial Research Inc · Ischemic Stroke

  • NoNO-42Phase 21 trial

    NoNO Inc. · Acute Ischemic Stroke

  • NTS-521Phase 21 trial

    NeuroTrauma Sciences, LLC · Acute Ischemic Stroke

  • QD202Phase 21 trial

    Shanghai QuietD Biotechnology Co., Ltd. · Acute Ischemic Stroke

  • QHRD106MiddlePhase 21 trial

    Changzhou Qianhong Bio-pharma Co., Ltd. · Acute Ischemic Stroke

  • RedasemtideRedasemtide trifluoroacetate, S-005151Phase 21 trial

    Shionogi · Acute Ischemic Stroke

  • scp776allPhase 21 trial

    Silver Creek Pharmaceuticals · Acute Ischemic Stroke (AIS)

  • TBO-309Phase 21 trial

    ThromBio Pty. Ltd. · Ischemic Stroke, Tandem Occlusion

  • XY03-EAper dosePhase 21 trial

    Shijiazhuang Yiling Pharmaceutical Co. Ltd · Stroke, Ischemic

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.